
© Bert Willer
Founder and co-organizer of the Digital Health Summit: Prof. Dr. Dominik Pförringer
November 12, 2026
PMC Redaktion
Artificial intelligence, digital diagnostics, and new technologies are transforming medicine. At the Digital Health Summit 2026 in Munich, leading scientists, physicians, founders, and investors explored how to turn cutting-edge research into better patient care — and why collaboration among Munich's leading institutions is key to making it happen

With
Univ.-Prof. Dr. med. Dominik Pförringer
In early November, TranslaTUM at TUM Klinikum rechts der Isar became the gathering place for digital medicine. Under the motto "AI meets HI – Sparking Innovation," the Digital Health Summit 2026 brought together scientists, physicians, technology companies, start-ups, and investors. The central message: the future of medicine is being shaped where artificial intelligence meets human expertise.
The topics on the agenda reflected what is happening in the field right now: artificial intelligence in diagnostics and therapy, brain-computer interfaces, wearables, digital hospital infrastructure, health data, and cybersecurity all took center stage. The discussions went beyond technical possibilities to address the most critical question of all: How do innovations actually travel from the research lab to the patient?
Munich is exceptionally well positioned for this challenge. TUM brings deep expertise in AI, medical technology, and entrepreneurship, while LMU excels in top-tier medical and natural science research. Together with the two university hospitals and Helmholtz Munich, they form a research and innovation ecosystem with an international reputation. The M1 Munich Medicine Alliance aims to consolidate these strengths and accelerate the translation of scientific findings into patient care.
The summit is driven primarily by the team behind TUM Venture Lab Healthcare and the faculties of both leading universities. Professors Björn Eskofier and Daniel Rückert are among the most prominent figures in medical AI research, while Dr. Nicolai Heinzelmann and Tobias Döringer are working to strengthen the connections between academia, founders, and investors.
What matters to all of them is the bridge: the collaboration between LMU and TUM, together with Helmholtz Munich, the Center for Digital Technology and Management (CDTM), OneAIM, baiosphere, and Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU).
The HTGF Digital Health Pitch Day, held immediately before the summit, underscored a simple truth: good research also requires capital, entrepreneurial courage, and access to clinical practice. Munich has the talent, the clinics, and the ideas.
The DHS serves as a catalyst for exchange between researchers and entrepreneurs. The two organizers, Dr. Nicolai Heinzelmann and Prof. Dr. Dominik Pförringer, expressed their gratitude to all supporters and partners. Together, they are committed to keeping this dialogue alive — and are already looking forward to the Healthcare Happy Hour on January 12 in Munich.

Artificial intelligence, digital diagnostics, and new technologies are transforming medicine. At the Digital Health Summit 2026 in Munich, leading scientists, physicians, founders, and investors explored how to turn cutting-edge research into better patient care — and why collaboration among Munich's leading institutions is key to making it happen
PMC Redaktion

With
Univ.-Prof. Dr. med. Dominik Pförringer

An injection for osteoarthritis pain – but which treatments actually make a difference? Orthopedic specialist Dr. Ferzan Süzer explains why she rarely uses cortisone for degenerative joint disease, what research reveals about hyaluronic acid and platelet-rich plasma, and why injections alone are not enough.
Christine Bürg & Marianne Waldenfels

An interview with
Dr. med. Ferzan Süzer

"Feel Good, Live Better" – In this episode, Dr. Birgit Dinnewitzer explains why small intestinal bacterial overgrowth is so often mistaken for irritable bowel syndrome.
Christine Bürg

An interview with
Dr. Birgit Dinnewitzer

The small button nose was long the ideal. For rhinoplasty surgeon Dr. Christian Jacobi, what matters today is a nose that suits the face and keeps its function. He explains how social media shapes what patients want and why nose fillers are riskier than many think.
Judith Cyriax

An interview with
Dr. med. Christian Jacobi

An upper eyelid lift is meant to make the eyes look more alert and youthful – but it isn’t always the right solution. Munich-based plastic surgeon Dr. Peter Neumann explains when he advises against surgery, which risks are often underestimated and why hooded eyelids can even impair vision.
Christine Bürg & Marianne Waldenfels

An interview with
Dr. med. Peter Neumann